# Folivex (Multivitamin) by Oncora Pharma, LLC: new human prescription drug listing

**Launch Signal Score:** 40/100

| Field | Value |
|---|---|
| Product | Folivex |
| Generic name | Multivitamin |
| NDC | 85477-906 |
| Labeler | Oncora Pharma, LLC |
| Product type | HUMAN PRESCRIPTION DRUG |
| Approval pathway | UNAPPROVED DRUG OTHER |
| Dosage form | TABLET |
| Route | ORAL |
| Active ingredients | FERROUS BISGLYCINATE 20 mg/1; POTASSIUM IODIDE .15 mg/1; PYRIDOXINE HYDROCHLORIDE 26 mg/1; BETA CAROTENE .3 mg/1; ASCORBIC ACID 60 mg/1; CHOLECALCIFEROL .1 mg/1; BIOTIN .28 mg/1; FOLIC ACID 1.67 mg/1 |
| Marketing start | 2026-10-22 |
| Package configurations | 1 |

## Why this score
- Prescription or biologic product.

Source: U.S. FDA National Drug Code (NDC) Directory via openFDA (https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=85477-906). Last refreshed: 2026-11-03T18:09:00.764Z.
Listing data comes from the FDA NDC directory via openFDA; a listing is not an FDA approval or endorsement and may be updated or withdrawn. Informational only; not medical advice.